News | October 05, 2010

VEITHsymposium to Highlight Vascular Disease Research, Clinical Findings


October 5, 2010 - The 37th annual VEITHsymposium, for vascular disease specialists, will be held Nov. 17 – 21 at the Hilton New York. The five-day event will feature more than 450 rapid-fire presentations from world-renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies, and new techniques.

The extended length and format allows the program to cover the diseases, conditions, diagnostic procedures, and medical interventions that comprise the landscape for vascular medicine. That includes treatment and management of patients with diseases of the veins and arteries, such as aneurysms, vessel blockage, traumatic lesions, thromboembolism, ischemia, stroke, peripheral arterial disease (PAD), carotid stenosis, and varicose veins. The conference also will deal with wound care, vascular access and other treatments of vascular problems or diseases approachable via the vascular system.

Additionally, the CREST Trial, which purported to show that stenting was equally effective as the more conventional surgical endarterectomy for treating carotid atherosclerosis and preventing stroke, is expected to draw attention at the symposium.

For more information: www.veithsymposium.org


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now